Chang Kim - InnoTherapy I America
| 246960 Stock | KRW 8,290 190.00 2.24% |
Executive
Chang Kim is I America of InnoTherapy
| Phone | 82 2 6959 1338 |
| Web | http://www.innotherapy.com |
InnoTherapy Management Efficiency
The company has return on total asset (ROA) of (0.1318) % which means that it has lost $0.1318 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (66.3433) %, meaning that it generated substantial loss on money invested by shareholders. InnoTherapy's management efficiency ratios could be used to measure how well InnoTherapy manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | EXECUTIVE Age | ||
| Hyeong Kim | Aprogen Healthcare Games | 59 | |
| Je Park | Aprogen Healthcare Games | 35 | |
Management Performance
| Return On Equity | -66.34 | |||
| Return On Asset | -0.13 |
InnoTherapy Leadership Team
Elected by the shareholders, the InnoTherapy's board of directors comprises two types of representatives: InnoTherapy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InnoTherapy. The board's role is to monitor InnoTherapy's management team and ensure that shareholders' interests are well served. InnoTherapy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InnoTherapy's outside directors are responsible for providing unbiased perspectives on the board's policies.
| HaeShin Lee, Founder CTO | ||
| Chang Kim, I America | ||
| Mi Koh, Head Center | ||
| Moonsue Lee, Founder CEO | ||
| In Moon, COO CFO |
InnoTherapy Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InnoTherapy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -66.34 | |||
| Return On Asset | -0.13 | |||
| Operating Margin | (6.16) % | |||
| Current Valuation | 84.92 B | |||
| Shares Outstanding | 5.04 M | |||
| Shares Owned By Insiders | 28.30 % | |||
| Shares Owned By Institutions | 0.20 % | |||
| Price To Sales | 97.27 X | |||
| Revenue | 507.29 M | |||
| Gross Profit | 339.33 M |
Pair Trading with InnoTherapy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InnoTherapy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will appreciate offsetting losses from the drop in the long position's value.Moving together with InnoTherapy Stock
| 0.75 | 102940 | Kolon Life Science | PairCorr |
| 0.67 | 074430 | Aminologics CoLtd | PairCorr |
| 0.78 | 023910 | Daihan Pharmaceutical | PairCorr |
| 0.83 | 047920 | HLB Pharmaceutical | PairCorr |
Moving against InnoTherapy Stock
The ability to find closely correlated positions to InnoTherapy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InnoTherapy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InnoTherapy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InnoTherapy to buy it.
The correlation of InnoTherapy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InnoTherapy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InnoTherapy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InnoTherapy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InnoTherapy Stock
InnoTherapy financial ratios help investors to determine whether InnoTherapy Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoTherapy with respect to the benefits of owning InnoTherapy security.